[1]
M. G. Lacambra, M. A. G. Martinez, V. G. Chumillas, and F. G. Tejero, “Renal Adverse Reaction Secondary to Check-point Inhibitors in Metastatic Renal Cancer”, J Clini Nephrol, vol. 8, no. 2, pp. 076–077, May 2024.